{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:47:04Z","timestamp":1747198024551,"version":"3.40.5"},"reference-count":5,"publisher":"Walter de Gruyter GmbH","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,25]]},"DOI":"10.1515\/cclm-2018-0245","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T22:16:03Z","timestamp":1524089763000},"page":"251-252","source":"Crossref","is-referenced-by-count":2,"title":["Letter to the Editor relative to Clin Chem Lab Med 2018;56(3):360\u2013372"],"prefix":"10.1515","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0689-7168","authenticated-orcid":false,"given":"Alain","family":"Gay","sequence":"first","affiliation":[{"name":"Bayer AG , M\u00fcllerstr. 178 , 13342 Berlin , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"2021021220090119469_j_cclm-2018-0245_ref_001_w2aab3b7c81b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Dick Sofia M, Queiroz M, Bernardi B\u00e1rbara L, Dall\u2019Agnol A, Brondani Let\u00edcia A, Silveiro Sandra P. Update in diagnosis and management of primary aldosteronism. Clin Chem Lab Med 2018;56:360\u201372.","DOI":"10.1515\/cclm-2017-0217"},{"key":"2021021220090119469_j_cclm-2018-0245_ref_002_w2aab3b7c81b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Bertram Pitt LK, Ponikowski P, Gheorghiade M, Filippatos G, Krum H, Nowack C, et al. Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial. Eur Heart J 2013;34:2453.","DOI":"10.1093\/eurheartj\/eht187"},{"key":"2021021220090119469_j_cclm-2018-0245_ref_003_w2aab3b7c81b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Filippatos G, Anker SD, B\u00f6hm M, Gheorghiade M, K\u00f8ber L, Krum H, et al. A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and\/or chronic kidney disease. Eur Heart J 2016;37:2105\u201314.","DOI":"10.1093\/eurheartj\/ehw132"},{"key":"2021021220090119469_j_cclm-2018-0245_ref_004_w2aab3b7c81b1b6b1ab2b1b4Aa","unstructured":"Kolkhof P, Delbeck M, Kretschmer A, Steinke W, Hartmann E, Baerfacker L, et al. Finerenone, a novel selective non-steroidal mineralocorticoid receptor antagonist with a balanced cardiorenal tissue distribution confers pronounced end organ protection at low natriuretic doses. Eu J Heart Failure 2014;16:210."},{"key":"2021021220090119469_j_cclm-2018-0245_ref_005_w2aab3b7c81b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Gromotowicz-Poplawska A, Szoka P, Kolodziejczyk P, Kramkowski K, Wojewodzka-Zelezniakowicz M, Chabielska E. New agents modulating the renin-angiotensin-aldosterone system \u2013 Will there be a new therapeutic option? Exp Biol Med 2016;241:1888\u201399.","DOI":"10.1177\/1535370216660211"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2018.56.issue-11\/cclm-2018-0245\/cclm-2018-0245.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2018-0245\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2018-0245\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T22:40:20Z","timestamp":1619044820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2018-0245\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":5,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,4,18]]},"published-print":{"date-parts":[[2018,10,25]]}},"alternative-id":["10.1515\/cclm-2018-0245"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2018-0245","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"type":"electronic","value":"1437-4331"},{"type":"print","value":"1434-6621"}],"subject":[],"published":{"date-parts":[[2018,4,18]]}}}